Latest News
Europe midday: Stocks lower as investors eye French election, Syria air strikes
European stocks were trading lower as the French election officially kicked-off on Monday, while investors were also keeping an eye on developments between Russia and the US following the US missile attack on Syria.
US pre-open: Stocks seen flat as investors eye Yellen speech
US futures pointed to a muted open on Wall Street on Monday as investors looked ahead to a speech by Federal Reserve Chair Janet Yellen and kept an eye on developments between the US and Russia after last week's missile strikes on Syria.
Hackers targeting Amazon third party sellers in account scam
Ecommerce giant Amazon has been hit by a wave of hackers in recent weeks, with third party sellers being targeted in a scam which saw thousands of pounds stolen from their accounts.
London midday: Stocks nudge lower as investors sift through corporate news
London stocks had drifted a little lower by midday as investors sifted through corporate news and kept an eye on developments between Russia and the US following the US missile attack on Syria last week.
Italian industrial production misses forecasts in February
Italian industrial production rose less than expected in February, leading to a small risk that economic growth in the first quarter of 2017 might undershoot some economists' forecasts.
First Property Group's shares rise as full-year profit seen in line
Shares in First Property Group rose as it said its full-year pre-tax earnings, prior to the profit on sale of the Romanian property last month, are seen to be in line with market views.
Monday broker round-up
AstraZeneca: Jefferies downgrades to Hold with a target price of 5050p.
Hornby shareholders looking to oust chairman
Model train set maker Hornby is set to hold a general meeting after it received a formal request from leading shareholders to remove chairman Roger Canham.
AstraZeneca slips on Jefferies downgrade over externalisation impact
AstraZeneca's strategy of disposals and 'externalising' revenues from selling licensing rights to its drugs will hit revenues and earnings more than the market realises, Jefferies said on Monday, downgrading its rating on the shares to 'hold' from 'buy'.
Highland Gold Mining swings to FY net profit as output slips
Shares in Highland Gold Mining are down more than 5% as it produced a full-year net profit of $47. 9m, which was a reversal of its year-earlier loss of $10. 0m, as its production slipped and all-in sustaining costs rose.
Amur Minerals completes ice road resupply for 2017 field season
Amur Minerals' shares are down after confirming the full restock and mobilisation of all newly bought machinery, spares and supplies for completion of its 2017 field season on its Kun-Manie nickel copper sulphide project in the Far East, Russia.
Russia mocks UK over Johnson's cancelled Moscow trip
UK foreign secretary Boris Johnson has been criticised by officials in Russia after he cancelled a planned visit to Moscow due to increasing tensions in the Syrian conflict.
Unite Group gains as student accommodation rents increase
The value of Unite Group’s student accommodation increased due to rental growth and stable yields in the first quarter.
Recording shows BoE pressured banks to lower Libor rates - BBC
A secret recording from 29 October 2008 could add to evidence the Bank of England pressured commercial banks to keep interest rates on the interbank market lower than they would otherwise have been, the BBC said.
Hikma boosted by Numis upgrade to 'buy'
Hikma Pharmaceuticals got a boost on Monday as Numis upgraded the stock to 'buy' from 'add'.
Grafenia sees FY EBITDA in line with revised market views, EBIT below
Grafenia says since its last update trading conditions have been mixed, with its full-year revenue, EBITDA and net cash seen in line with revised market expectations, but EBIT expected to be below them.
Cerillion sees jump in half-year profit and revenue
Cerillion said on Monday that the first half of the year has progressed well and results are anticipated to be in line with management's expectations for a 9% jump in revenue and a 36% rise in core earnings compared to the same period a year ago.
Stada surges as it backs Cinven, Bain Capital offer
Shares in Stada Arzneimittel surged on Monday after the German drug maker backed an offer from Bain Capital and Cinven at €66 a share, valuing the group at around €5. 32bn.
Bacanora Minerals enters into a strategic partnership to supply lithium carbonate
Bacanora Minerals has entered into a strategic partnership with Japan’s Hanwa Co, one of the larger traders of battery chemicals in Asia, which comprises of a 10% equity investment and an off-take agreement for up to 100% of the battery grade lithium carbonate produced at its Sonora project in Mexico.
Europe open: Single currency slips below 1.06 as polls show Melenchon gaining in polls
Stocks began the holiday-shortened week higher despite the latest poll results showing French far-Left candidate Jean Luc Melenchon was fast gaining support and following an apparently uneventful summit between US president Donald Trump and his Chinese counterpart.